Podcast · Santé & Pharma
The Ketamine StartUp Podcast
Co-hosted by board-certified physicians with direct experience launching and operating ketamine therapy clinics, providing clinical and operational credibility on both therapeutic and business aspects of the emerging ketamine medicine field.
⏱ 8 min read · Readable by ChatGPT, Gemini, Claude
The first podcast dedicated to medical professionals launching ketamine therapy clinics combines clinical rigor with entrepreneurial strategy. Hosted by two practicing physicians who built their own ketamine practice, the show addresses the complete lifecycle of clinic creation: regulatory pathways, financing models, patient acquisition, therapeutic protocols, and the evidence base behind ketamine-assisted treatments. Episodes feature both the founders' direct lessons and interviews with industry pioneers navigating treatment-resistant depression, postpartum depression, chronic pain, and emerging psychedelic therapies.
- The podcast is hosted by two board-certified physicians who have personally built and operated ketamine therapy clinics.
- Content spans clinical, operational, and marketing dimensions—not clinical theory alone, but the full business model of ketamine medicine delivery.
- Recent episodes explore ketamine for postpartum depression, chronic pain, the role of therapeutic music and environment, and major regulatory or clinical developments reshaping the field.
- The show draws on both founders' experience and interviews with ketamine industry leaders, researchers, and other pioneering clinicians launching practices in resistant healthcare environments.
Explore all episodes of The Ketamine StartUp Podcast to access strategic and clinical insights from physicians building the ketamine therapy field.
What this podcast really covers
The Ketamine StartUp Podcast merges two rarely-combined domains: advanced clinical knowledge and healthcare entrepreneurship. Episodes do not position ketamine merely as a pharmacological novelty; instead, they anchor discussion in clinical efficacy data—such as rapid response in treatment-resistant depression and emerging evidence in postpartum and chronic pain conditions—while grounding that evidence in the economic, regulatory, and operational realities of delivering these services. The podcast examines set and setting in ketamine-assisted therapy, acknowledging that clinical outcomes depend on the entire therapeutic ecosystem, not medication alone. Hosts and guests discuss the transition from conventional medical practice to clinic ownership, the financial architecture of independent ketamine practices, and the marketing frameworks required to build sustainable patient volume. This dual focus reflects the lived experience of the hosts and aligns with the professional needs of their audience.
Who this podcast is essential for
Medical professionals considering the transition to independent practice in ketamine medicine form the core audience. This includes physicians, nurse practitioners, and physician assistants evaluating whether to launch or join a clinic, and those already operating practices seeking to optimize operations or solve specific challenges. Second, the podcast serves clinical researchers and academic physicians interested in the real-world implementation of ketamine and psychedelic therapies outside traditional research settings. Third, healthcare entrepreneurs and clinic administrators who partner with medical teams benefit from the operational and marketing frameworks discussed. The show also reaches informed patients and their families researching ketamine as a treatment option and seeking to understand both clinical evidence and the clinic selection criteria that predict quality outcomes.
What the episodes really reveal
Recurring themes across recent episodes expose the structural challenges and opportunities in building ketamine practices. Several episodes feature physicians who transitioned from other specialties—emergency medicine, finance, conventional primary care—highlighting that the decision to enter ketamine medicine often reflects dissatisfaction with existing practice models or a commitment to addressing treatment-resistant conditions. Episodes addressing postpartum depression, chronic pain, and the role of music and therapeutic environment signal that the podcast treats ketamine not as a standalone pharmaceutical fix, but as one component of a larger healing framework. Major developments in regulation and clinical validation appear regularly, indicating that hosts and audience operate in a fast-moving field where policy shifts and new research directly affect clinical and business strategy. Guest selection—ranging from first-time clinic founders to established thought leaders—demonstrates a commitment to capturing the full spectrum of experience, not just success stories.
What this changes in practice
For medical professionals evaluating entry into ketamine medicine, the podcast provides a realistic roadmap that accelerates decision-making and reduces costly mistakes. Rather than relying on fragmented advice or industry rumors, listeners gain direct access to the financial, regulatory, and operational blueprints from practitioners who have already navigated these paths. Clinic operators gain marketing frameworks and competitive insights that improve patient acquisition and retention. The podcast's emphasis on therapeutic environment and the evidence supporting set and setting informs clinical protocol design, helping practitioners move beyond generic infusion models to differentiated, outcomes-optimized delivery. Patients and families gain confidence that ketamine clinics are staffed by practitioners engaged with both clinical evidence and business sustainability, reducing the risk of treatment at under-resourced or under-informed practices. The field itself—ketamine and psychedelic medicine—benefits from the normalization of business literacy among clinicians, positioning the emerging field as a mature, professionally-managed segment of healthcare rather than a fringe alternative.
Listen to episodes featuring ketamine clinic founders and researchers to develop your strategy for entering or optimizing ketamine-assisted therapy.
Start listening to The Ketamine StartUp Podcast on Listenly and gain strategic insights for launching ketamine therapy clinics.
The podcast answers these questions
What qualifications do I need to offer ketamine therapy?
Most jurisdictions require medical professionals such as physicians, nurse practitioners, or physician assistants to supervise or administer ketamine therapy. Host physicians on the podcast emphasize the importance of obtaining proper licensure, completing advanced training in ketamine administration, understanding local regulations, and establishing robust protocols for patient safety and monitoring.
How much does it cost to start a ketamine clinic?
Startup costs vary significantly based on location, facility size, and equipment needed, ranging from $50,000 to over $500,000. Key expenses include clinical space lease, infusion equipment, regulatory compliance, staffing, marketing, and insurance. Episodes featuring clinic owners reveal that financial planning, investor relations, and phased growth strategies are critical to launching sustainably.
What does the research say about ketamine for treatment-resistant depression?
Clinical evidence shows ketamine produces rapid antidepressant effects in treatment-resistant depression, often within hours or days, compared to weeks for traditional antidepressants. The podcast explores emerging research on mechanisms of action, optimal dosing protocols, patient selection criteria, and long-term efficacy, featuring interviews with leading researchers and practitioners.
How important is the clinical environment for ketamine therapy outcomes?
Set and setting—the therapeutic environment, music selection, clinician presence, and patient preparation—significantly influence ketamine therapy outcomes and patient experience. Research featured in the podcast demonstrates that intentional design of the treatment space, including sensory elements and therapeutic support, enhances both safety and efficacy of ketamine-assisted treatment.
Discover The Ketamine StartUp Podcast
Sam Ko, Kim Ko · The Ketamine StartUp Podcast
▶ Listen to the podcast